Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00780273 · ClinicalTrials.gov registry record · Phase 4

Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses

A Phase 4 study of Edentulism, sponsored by Dentsply International.

Completed
Registry status
Phase 4
Development phase
19
Enrollment target
1
Study location

NCT00780273 is a Phase 4 study of Edentulism that has completed, run by Dentsply International. The registered enrollment target is 19 participants, below the 190-participant average among 4 other Edentulism trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00780273, a Phase 4 study of Edentulism, has completed, sponsored by Dentsply International.

COMPLETED
Registry status
Phase 4
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Change in crestal bone level implants at 5% significance level.

Conditions Studied

Interventions

  • DEVICE Ankylos Implants
  • DEVICE Biomet 3i Prevail Implants

Study Locations (1)

New York

  • University of Rochester, Eastman Dept of Dentistry - Rochester

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2008-09
Est. Completion 2012-04
Phase Phase 4

Sponsor

Dentsply International

6 total trials

What the Registry Record Tells You About NCT00780273

The ClinicalTrials.gov registry entry for NCT00780273 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 4 other Edentulism trials with a reported enrollment target (90% lower). The listed sponsor is Dentsply International, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Edentulism appearing as the primary indexed condition, and to 2 interventions - of which Ankylos Implants is the first listed.

NCT00780273 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00780273 about?

NCT00780273 is a clinical study titled "Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses". Change in crestal bone level implants at 5% significance level.

What is the current status of trial NCT00780273?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2008-09. Estimated completion is 2012-04.

What conditions does trial NCT00780273 study?

This clinical trial studies the following conditions: Edentulism.

What interventions are being tested in trial NCT00780273?

The interventions under investigation include: Ankylos Implants (DEVICE), Biomet 3i Prevail Implants (DEVICE).

Who is sponsoring clinical trial NCT00780273?

This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00780273 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Edentulism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.